image
Basic Materials - Chemicals - Specialty - NASDAQ - US
$ 177.77
0.537 %
$ 5.78 B
Market Cap
47.92
P/E
1. INTRINSIC VALUE

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications.[ Read More ]

The intrinsic value of one BCPC stock under the base case scenario is HIDDEN Compared to the current market price of 178 USD, Balchem Corporation is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart BCPC

image
FINANCIALS
922 M REVENUE
-2.11%
178 M OPERATING INCOME
22.67%
109 M NET INCOME
3.01%
184 M OPERATING CASH FLOW
32.64%
-34.8 M INVESTING CASH FLOW
91.63%
-153 M FINANCING CASH FLOW
-62.15%
240 M REVENUE
2.50%
48 M OPERATING INCOME
4.49%
33.8 M NET INCOME
5.51%
51.3 M OPERATING CASH FLOW
14.02%
-9.18 M INVESTING CASH FLOW
-33.89%
-34.4 M FINANCING CASH FLOW
-0.60%
Balance Sheet Decomposition Balchem Corporation
image
Current Assets 314 M
Cash & Short-Term Investments 64.4 M
Receivables 125 M
Other Current Assets 125 M
Non-Current Assets 1.31 B
Long-Term Investments 4.08 M
PP&E 296 M
Other Non-Current Assets 1.01 B
Current Liabilities 148 M
Accounts Payable 55.5 M
Short-Term Debt 8.44 M
Other Current Liabilities 84.5 M
Non-Current Liabilities 423 M
Long-Term Debt 326 M
Other Non-Current Liabilities 96.6 M
EFFICIENCY
Earnings Waterfall Balchem Corporation
image
Revenue 922 M
Cost Of Revenue 620 M
Gross Profit 302 M
Operating Expenses 124 M
Operating Income 178 M
Other Expenses 69.6 M
Net Income 109 M
RATIOS
32.75% GROSS MARGIN
32.75%
19.31% OPERATING MARGIN
19.31%
11.77% NET MARGIN
11.77%
10.30% ROE
10.30%
6.68% ROA
6.68%
10.30% ROIC
10.30%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Balchem Corporation
image
Net Income 109 M
Depreciation & Amortization 54.4 M
Capital Expenditures -37.9 M
Stock-Based Compensation 16.1 M
Change in Working Capital 20 M
Others -5.48 M
Free Cash Flow 146 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Balchem Corporation
image
Wall Street analysts predict an average 1-year price target for BCPC of $190 , with forecasts ranging from a low of $190 to a high of $190 .
BCPC Lowest Price Target Wall Street Target
190 USD 6.88%
BCPC Average Price Target Wall Street Target
190 USD 6.88%
BCPC Highest Price Target Wall Street Target
190 USD 6.88%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0.79 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership Balchem Corporation
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
2.25 M USD 2
6-9 MONTHS
18.5 M USD 6
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
3 months ago
Jul 31, 2024
Sell 1.4 M USD
van Gunsteren Job Leonard
SVP and GM, Specialty Products
- 7750
180.0531 USD
3 months ago
Jul 30, 2024
Sell 640 K USD
Backus William A.
VP & Chief Accounting Officer
- 3570
179.247 USD
3 months ago
Jul 30, 2024
Sell 59.6 K USD
Backus William A.
VP & Chief Accounting Officer
- 330
180.4656 USD
3 months ago
Jul 30, 2024
Sell 160 K USD
Backus William A.
VP & Chief Accounting Officer
- 904
177.0955 USD
6 months ago
May 10, 2024
Sell 298 K USD
Sestrick Michael Robert
SVP & Chief Technology Officer
- 1929
154.4503 USD
6 months ago
May 08, 2024
Sell 667 K USD
Fischer David B
Director
- 4363
152.847 USD
6 months ago
May 08, 2024
Sell 98 K USD
Fischer David B
Director
- 637
153.894 USD
8 months ago
Mar 08, 2024
Sell 512 K USD
Tignor Michael Brent
SVP & Chief HR Officer
- 3261
157.0675 USD
8 months ago
Mar 08, 2024
Sell 329 K USD
Tignor Michael Brent
SVP & Chief HR Officer
- 2078
158.2233 USD
8 months ago
Mar 04, 2024
Sell 209 K USD
Wineinger Matthew David
Director
- 1333
156.8851 USD
8 months ago
Feb 23, 2024
Sell 1.05 M USD
Backus William A.
VP & Chief Accounting Officer
- 6703
156.1575 USD
8 months ago
Feb 23, 2024
Sell 389 K USD
Backus William A.
VP & Chief Accounting Officer
- 2477
156.9418 USD
8 months ago
Feb 26, 2024
Sell 398 K USD
Backus William A.
VP & Chief Accounting Officer
- 2581
154.3617 USD
8 months ago
Feb 26, 2024
Sell 672 K USD
Backus William A.
VP & Chief Accounting Officer
- 4319
155.6573 USD
8 months ago
Feb 26, 2024
Sell 15.6 K USD
Backus William A.
VP & Chief Accounting Officer
- 100
156.13 USD
8 months ago
Feb 21, 2024
Sell 120 K USD
Backus William A.
VP & Chief Accounting Officer
- 784
153.4388 USD
8 months ago
Feb 21, 2024
Sell 2.19 M USD
Backus William A.
VP & Chief Accounting Officer
- 14139
154.8017 USD
8 months ago
Feb 21, 2024
Sell 12 K USD
Backus William A.
VP & Chief Accounting Officer
- 77
155.6849 USD
8 months ago
Feb 21, 2024
Sell 1.7 M USD
Sestrick Michael Robert
SVP & Chief Technology Officer
- 11100
153.2084 USD
8 months ago
Feb 22, 2024
Sell 2.23 M USD
Harris Theodore L
Chairman, President & CEO
- 14497
153.5564 USD
8 months ago
Feb 21, 2024
Sell 1.65 M USD
Harris Theodore L
Chairman, President & CEO
- 10797
152.9738 USD
8 months ago
Feb 22, 2024
Sell 2.16 M USD
Harris Theodore L
Chairman, President & CEO
- 13989
154.66 USD
8 months ago
Feb 21, 2024
Sell 2.46 M USD
Harris Theodore L
Chairman, President & CEO
- 16015
153.7461 USD
8 months ago
Feb 21, 2024
Sell 413 K USD
Harris Theodore L
Chairman, President & CEO
- 2667
154.8359 USD
8 months ago
Feb 21, 2024
Sell 31.2 K USD
Harris Theodore L
Chairman, President & CEO
- 200
155.91 USD
8 months ago
Feb 22, 2024
Sell 910 K USD
Harris Theodore L
Chairman, President & CEO
- 5864
155.249 USD
1 year ago
Sep 11, 2023
Sell 500 K USD
Fischer David B
Director
- 3800
131.5733 USD
1 year ago
May 02, 2023
Sell 300 K USD
Sestrick Michael Robert
SVP & Chief Technology Officer
- 2300
130.3638 USD
1 year ago
Mar 20, 2023
Sell 381 K USD
Fischer David B
Director
- 3000
127.007 USD
2 years ago
Aug 12, 2022
Sell 131 K USD
van Gunsteren Job Leonard
director: Vice President
- 1000
131.1207 USD
2 years ago
Aug 05, 2022
Sell 334 K USD
van Gunsteren Job Leonard
director: Vice President
- 2629
127.0079 USD
2 years ago
Aug 03, 2022
Sell 175 K USD
van Gunsteren Job Leonard
director: Vice President
- 1401
125.0165 USD
3 years ago
Aug 06, 2021
Sell 1.64 M USD
Backus William A.
Chief Accounting Officer
- 12248
134.04 USD
3 years ago
Aug 09, 2021
Sell 1.39 M USD
Backus William A.
Chief Accounting Officer
- 10520
132.02 USD
4 years ago
Nov 13, 2020
Sell 309 K USD
MASON SCOTT C
Vice President
- 3000
103 USD
5 years ago
Aug 30, 2019
Sell 962 K USD
LUDWIG DAVID F
Vice President, Specialty & In
- 10688
90 USD
5 years ago
Aug 05, 2019
Bought 254 K USD
MASON SCOTT C
Vice President
+ 3000
84.74 USD
6 years ago
Nov 13, 2018
Bought 57.9 K USD
Knutson Daniel E
Director
+ 650
89.11 USD
7 years ago
Jun 15, 2017
Sell 207 K USD
MCMILLAN EDWARD
Director
- 2556.59
81.085 USD
7 years ago
Mar 13, 2017
Sell 4.05 M USD
Backus William A.
CFO and Treasurer
- 48500
83.5973 USD
7 years ago
Mar 03, 2017
Sell 1.22 M USD
Backus William A.
CFO and Treasurer
- 14000
86.875 USD
7 years ago
Jan 03, 2017
Sell 62.2 K USD
ROSSI DINO A
- 747
83.26 USD
7 years ago
Jan 04, 2017
Sell 132 K USD
MCMILLAN EDWARD
Director
- 1550
85 USD
7 years ago
Dec 07, 2016
Sell 682 K USD
ROSSI DINO A
Director
- 8200
83.1501 USD
7 years ago
Dec 08, 2016
Sell 738 K USD
ROSSI DINO A
Director
- 8562
86.1508 USD
8 years ago
Nov 15, 2016
Sell 638 K USD
ROSSI DINO A
Director
- 8200
77.8139 USD
8 years ago
Nov 16, 2016
Sell 639 K USD
ROSSI DINO A
Director
- 8200
77.8811 USD
8 years ago
Oct 06, 2016
Sell 645 K USD
ROSSI DINO A
Director
- 8200
78.62 USD
8 years ago
Oct 07, 2016
Sell 644 K USD
ROSSI DINO A
Director
- 8200
78.5115 USD
8 years ago
Sep 20, 2016
Sell 271 K USD
Houston Matthew David
General Counsel/Secretary
- 4000
67.83 USD
8 years ago
Sep 08, 2016
Sell 567 K USD
ROSSI DINO A
Director
- 8200
69.1245 USD
8 years ago
Sep 09, 2016
Sell 553 K USD
ROSSI DINO A
Director
- 8200
67.3955 USD
8 years ago
Sep 02, 2016
Sell 105 K USD
MCMILLAN EDWARD
Director
- 1500
69.746 USD
8 years ago
Aug 26, 2016
Sell 824 K USD
Backus William A.
CFO and Treasurer
- 12000
68.64 USD
8 years ago
Aug 09, 2016
Sell 534 K USD
ROSSI DINO A
Director
- 8200
65.1322 USD
8 years ago
Aug 10, 2016
Sell 537 K USD
ROSSI DINO A
Director
- 8200
65.4797 USD
8 years ago
Jul 13, 2016
Sell 532 K USD
ROSSI DINO A
Director
- 8400
63.3731 USD
8 years ago
Jul 14, 2016
Sell 502 K USD
ROSSI DINO A
Director
- 8200
61.2165 USD
8 years ago
Jun 16, 2016
Sell 1.1 M USD
ROSSI DINO A
Director
- 18481
59.5709 USD
8 years ago
Jun 17, 2016
Sell 822 K USD
ROSSI DINO A
Director
- 13919
59.057 USD
8 years ago
Jun 20, 2016
Sell 4.58 K USD
MCMILLAN EDWARD
Director
- 76
60.25 USD
8 years ago
Jun 20, 2016
Sell 181 K USD
MCMILLAN EDWARD
Director
- 3000
60.247 USD
8 years ago
May 19, 2016
Sell 11.7 K USD
ROSSI DINO A
Director
- 200
58.39 USD
8 years ago
May 13, 2016
Sell 31.5 K USD
Houston Matthew David
General Counsel/Secretary
- 500
63.012 USD
8 years ago
May 16, 2016
Sell 281 K USD
Houston Matthew David
General Counsel/Secretary
- 4500
62.4512 USD
8 years ago
Apr 20, 2016
Sell 517 K USD
ROSSI DINO A
Director
- 8200
63.1034 USD
8 years ago
Apr 19, 2016
Sell 518 K USD
ROSSI DINO A
Director
- 8200
63.1873 USD
8 years ago
Mar 23, 2016
Sell 488 K USD
ROSSI DINO A
Director
- 8200
59.4904 USD
8 years ago
Mar 22, 2016
Sell 491 K USD
ROSSI DINO A
Director
- 8200
59.8636 USD
9 years ago
Nov 06, 2015
Sell 414 K USD
TELEVANTOS JOHN Y
Director
- 6435
64.406 USD
9 years ago
Sep 15, 2015
Sell 420 K USD
ROSSI DINO A
Chairman
- 7300
57.596 USD
9 years ago
Sep 16, 2015
Sell 438 K USD
ROSSI DINO A
Chairman
- 7300
60.02 USD
9 years ago
Aug 13, 2015
Sell 444 K USD
ROSSI DINO A
Executive Chairman
- 7300
60.7987 USD
9 years ago
Aug 14, 2015
Sell 441 K USD
ROSSI DINO A
Executive Chairman
- 7300
60.3712 USD
9 years ago
Aug 10, 2015
Sell 924 K USD
LUDWIG DAVID F
VP/Gen Mgr/ARC Spec Prods
- 15000
61.5892 USD
9 years ago
Jul 14, 2015
Sell 402 K USD
ROSSI DINO A
Executive Chairman
- 7300
55.0359 USD
9 years ago
Jul 15, 2015
Sell 406 K USD
ROSSI DINO A
Executive Chairman
- 7300
55.5832 USD
9 years ago
Jul 13, 2015
Sell 826 K USD
LUDWIG DAVID F
VP/Gen Mgr/ARC Spec Prods
- 15000
55.0489 USD
9 years ago
Jun 12, 2015
Sell 914 K USD
FITZPATRICK FRANK
Vice President Administration
- 14935
61.1965 USD
9 years ago
Jun 10, 2015
Sell 440 K USD
ROSSI DINO A
President & CEO
- 7300
60.327 USD
9 years ago
Jun 11, 2015
Sell 442 K USD
ROSSI DINO A
President & CEO
- 7300
60.5685 USD
9 years ago
Jun 10, 2015
Sell 895 K USD
LUDWIG DAVID F
VP/Gen Mgr/ARC Spec Prods
- 15000
59.6559 USD
9 years ago
May 15, 2015
Sell 799 K USD
FITZPATRICK FRANK
Vice President Administration
- 14000
57.0953 USD
9 years ago
May 12, 2015
Sell 548 K USD
LUDWIG DAVID F
VP/Gen Mgr/ARC Spec Prods
- 9750
56.2177 USD
9 years ago
May 11, 2015
Sell 269 K USD
LUDWIG DAVID F
VP/Gen Mgr/ARC Spec Prods
- 4701
57.161 USD
9 years ago
May 07, 2015
Sell 422 K USD
ROSSI DINO A
Director
- 7300
57.8754 USD
9 years ago
May 08, 2015
Sell 420 K USD
ROSSI DINO A
Director
- 7300
57.5687 USD
9 years ago
May 07, 2015
Sell 1.66 M USD
LUDWIG DAVID F
VP/Gen Mgr/ARC Spec Prods
- 28500
58.1421 USD
9 years ago
Apr 16, 2015
Sell 87.4 K USD
LUDWIG DAVID F
VP/Gen Mgr/ARC Spec Prods
- 1500
58.255 USD
9 years ago
Apr 15, 2015
Sell 776 K USD
FITZPATRICK FRANK
Vice President Administration
- 14000
55.4278 USD
9 years ago
Apr 06, 2015
Sell 410 K USD
ROSSI DINO A
President & CEO
- 7300
56.206 USD
9 years ago
Apr 07, 2015
Sell 406 K USD
ROSSI DINO A
President & CEO
- 7300
55.5961 USD
9 years ago
Mar 16, 2015
Sell 785 K USD
FITZPATRICK FRANK
Vice President Administration
- 14000
56.0663 USD
9 years ago
Mar 03, 2015
Sell 428 K USD
ROSSI DINO A
President & CEO
- 7300
58.663 USD
9 years ago
Mar 04, 2015
Sell 420 K USD
ROSSI DINO A
President & CEO
- 7300
57.562 USD
7. News
Here's Why Momentum in Blachem (BCPC) Should Keep going If you are looking for stocks that are well positioned to maintain their recent uptrend, Blachem (BCPC) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen. zacks.com - 1 week ago
Blachem (BCPC) Upgraded to Strong Buy: Here's What You Should Know Blachem (BCPC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. zacks.com - 2 weeks ago
Balchem Corporation to Present at Baird's 54th Annual Global Industrial Conference on November 13, 2024 MONTVALE, N.J., Nov. 01, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at Baird's 54th Annual Global Industrial Conference on November 13, 2024. globenewswire.com - 2 weeks ago
Are Basic Materials Stocks Lagging Balchem (BCPC) This Year? Here is how Blachem (BCPC) and Barrick Gold (GOLD) have performed compared to their sector so far this year. zacks.com - 2 weeks ago
Balchem's Q3 Shows Record Earnings And Valuation Pressure Balchem Corporation shows strong long-term growth potential in high-margin segments and product innovation, but faces challenges in Animal Nutrition & Health and rising costs. Balchem's financial momentum in Q3 2024 includes record earnings, improved margins, and significant debt reduction, despite missing revenue estimates. BCPC stock's high P/E ratio of 39.82x suggests big market expectations, but the current valuation may be too high given existing challenges. seekingalpha.com - 2 weeks ago
Balchem Corporation (BCPC) Q3 2024 Earnings Call Transcript Balchem Corporation (NASDAQ:BCPC ) Q3 2024 Earnings Conference Call October 25, 2024 11:00 AM ET Company Participants Martin Bengtsson - Chief Financial Officer Ted Harris - Chairman, President and Chief Executive Officer Conference Call Participants Robert Labick - CJS Securities Raghuram Selvaraju - H.C. Wainwright & Co Kyle May - Sidoti and Company Operator Greetings, and welcome to the Balchem's Third Quarter 2024 Earnings Call. seekingalpha.com - 3 weeks ago
Blachem (BCPC) Matches Q3 Earnings Estimates Blachem (BCPC) came out with quarterly earnings of $1.03 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.90 per share a year ago. zacks.com - 3 weeks ago
Balchem Corporation Reports Third Quarter 2024 Financial Results MONTVALE, N.J., Oct. 25, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) reported today financial results for its 2024 fiscal third quarter ended September 30, 2024. For the quarter, the Company reported net sales of $239.9 million, net earnings of $33.8 million, adjusted EBITDA(a) of $64.4 million, and free cash flow(a) of $42.2 million. globenewswire.com - 3 weeks ago
Balchem Corporation Announces Quarterly Conference Call for Third Quarter Financial Results on October 25, 2024 MONTVALE, N.J., Oct. 11, 2024 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, October 25, 2024, at 11:00 AM Eastern Time (ET) to review third quarter results. globenewswire.com - 1 month ago
All You Need to Know About Blachem (BCPC) Rating Upgrade to Strong Buy Blachem (BCPC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. zacks.com - 1 month ago
What Makes Blachem (BCPC) a Good Fit for 'Trend Investing' Blachem (BCPC) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen. zacks.com - 2 months ago
Blachem (BCPC) Upgraded to Strong Buy: What Does It Mean for the Stock? Blachem (BCPC) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. zacks.com - 2 months ago
8. Profile Summary

Balchem Corporation BCPC

image
COUNTRY US
INDUSTRY Chemicals - Specialty
MARKET CAP $ 5.78 B
Dividend Yield 0.00%
Description Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.
Contact 52 Sunrise Park Road, New Hampton, NY, 10958 https://www.balchem.com
IPO Date June 3, 1986
Employees 1300
Officers Mr. Carl Martin Bengtsson Executive Vice President, Chief Financial Officer, Treasurer & GM of Animal Nutrition and Health Mr. Jonathan H. Griffin Senior Vice President of Corporate Development Mr. Frederic Boned Senior Vice President and GM of Human Nutrition & Health Mr. Michael R. Sestrick Ph.D. Senior Vice President & Chief Technology Officer Ms. Hatsuki Miyata Executive Vice President, General Counsel & Secretary Mr. Job L. van Gunsteren Senior Vice President & GM of Specialty Products Mr. M. Brent Tignor Senior Vice President & Chief Human Resources Officer Mr. William A. Backus CPA Vice President & Chief Accounting Officer Mr. Theodore L. Harris Chairman, Chief Executive Officer & President Mr. Martin Luther Reid Senior Vice President & Chief Supply Chain Officer